Global Fund's Technical Review Panel Recommends Zimbabwe's Funding Application Be Approved

Main Category: HIV / AIDS
Also Included In: Tuberculosis
Article Date: 29 Oct 2008 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


The Technical Review Panel of the Global Fund to Fight AIDS, Tuberculosis and Malaria has recommended that Zimbabwe's Round 8 application to scale up HIV/AIDS and tuberculosis programs in the country be approved, IRIN/PlusNews reports. Zimbabwe's "relationship with the Global Fund has not been a rosy one," IRIN//PlusNews reports, adding that "in seven rounds of funding disbursements, Zimbabwe's applications have been successful in only two."

The TRP -- an independent group of health experts and academics that reviews all Global Fund applications -- has said Zimbabwe's application for at least $500 million is "technically sound." Zimbabwe's Country Coordinating Mechanism requested about $300 million for HIV/AIDS efforts, $58 million for TB programs and $80 million to improve the country's health sector. Douglas Gwatidzo, chair of the Zimbabwean Association of Doctors for Human Rights, said the decision to apply for health system strengthening was "very wise" because the effectiveness of HIV/AIDS, TB and malaria programs will depend on the capacity of health systems. The Global Fund's board of directors will meet in New Delhi in November to review and approve Round 8 funding applications.

Zimbabwean Health Minister David Parirenyatwa said the country is "delighted" that TRP has recommended that Zimbabwe's application be approved because the country's "financial coffers had run dry" and additional funding would be a "welcome relief." Jon Liden, head of communications at the Global Fund, said that it would be "premature" to announce that the application would be approved in advance of November's board meeting. Gwatidzo agreed that it might be too early to assume approval, adding that Zimbabwe has an "urgent need of HIV/AIDS funding" and should seek alternative solutions while waiting for a possible Global Fund grant (IRIN/PlusNews, 10/24).

Zimbabwe has an HIV prevalence rate of about 15.3%, and about 1.3 million people in the country are HIV-positive. About 98,000 HIV-positive people in the country have access to no-cost HIV treatment provided by the government, but about 570,000 people are in need of antiretroviral drugs (GlobalHealthFacts.org)

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation.  All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our hiv / aids section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "Global Fund's Technical Review Panel Recommends Zimbabwe's Funding Application Be Approved." Medical News Today. MediLexicon, Intl., 29 Oct. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/127280.php>

APA
Kaiser. (2008, October 29). "Global Fund's Technical Review Panel Recommends Zimbabwe's Funding Application Be Approved." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/127280.php.

Please note: If no author information is provided, the source is cited instead.




HIV / AIDS

Most Popular Articles



Follow Our HIV News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our HIV / AIDS Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »